InvestorsHub Logo
Followers 0
Posts 16
Boards Moderated 0
Alias Born 09/20/2006

Re: jellybean post# 3036

Wednesday, 09/20/2006 5:24:46 PM

Wednesday, September 20, 2006 5:24:46 PM

Post# of 6489
This is my last post for day..... (limited to 3 ihub posts for moment)...

Evidently they're going for orphan status in EU for rhIGFBP3 complex according to EU COMP committee. When you say "they have been working for years..." do you mean with INSM/CTRX or just that ROP Pharma's been working on indication for years. I am not aware of any INSM collaborations with ROP (and I've been INSM investor a long time). I am looking at this from the perspective that wouldn't want INSM / iPlex to be blocked from EU market for this indication if ROP Pharma is in a position to bring a product to market w/ orphan status. I am not too aware of ROP Pharma's position. I haven't seen any mention or discusssions of them as a player in the rhIGF markets prior to this orphan filing... Have you seen any info about INSM starting ROP trials in EU (or any other market for that matter)?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News